Neuronavigation Systems Market Report 2024

The neuronavigation systems market size has grown strongly in recent years. It will grow from $2.12 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The expansion observed during the historical period can be attributed to several factors, including enhanced safety and precision in neurosurgery, rising demand for neuro-navigation systems, increased risk of neurological diseases' clinical onset and progression, growing funding and investment, and longer average life expectancy.

The neuronavigation systems market size is expected to see strong growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period is due to the escalating need for precise systems, the increasing prevalence of neurological disorders such as cancer, a higher incidence rate of these disorders, and rising healthcare expenditure. Key trends expected in the forecast period include the adoption of computer-assisted technologies, the integration of augmented reality (AR), artificial intelligence (AI), and machine learning (ML), as well as advancements in electromagnetic technology and robotics in neurosurgery.

The rise in neurological disorders is anticipated to drive the growth of neuronavigation systems in the future. These disorders predominantly impact the brain, spinal cord, and peripheral nerves. Factors contributing to the increased incidence include an aging population, environmental pollutants and toxins, poor dietary habits, nutritional deficiencies, and advancements in diagnostic technology. Neuronavigation systems assist surgeons in performing brain surgeries with greater accuracy, thus minimizing risks and enhancing outcomes for patients with neurological conditions such as brain tumors and epilepsy. They provide real-time imaging and brain mapping, improving detection of these conditions. Contributing factors include environmental elements, lifestyle modifications such as diet and exercise, and occasionally genetic predispositions. For example, the World Health Organization (WHO) reported that, in 2021, neurological conditions affected over one-third of the global population, making them a leading cause of illness and disability worldwide. Currently, more than 3 billion people globally are living with neurological conditions. Consequently, the growing prevalence of these disorders is driving the demand for neuronavigation systems.

Key players in the neuronavigation systems market are focusing on developing cutting-edge solutions, such as the portable microelectrode recording (MER) navigation system, to improve surgical precision and patient outcomes. This advanced medical device is used primarily in neurosurgery, especially for deep brain stimulation (DBS) procedures. It helps in accurately positioning electrodes within the brain by recording neuronal electrical activity. For instance, in April 2024, Medtronic, a medical device company based in Ireland, introduced the NeuroSmart Portable Micro Electrode Recording (MER) Navigation System in India. This system is specifically designed for managing Parkinson's disease through DBS procedures, targeting symptoms such as tremors, stiffness, and walking difficulties. The NeuroSmart system features advanced neurophysiological navigation mapping, allowing for precise electrode placement and optimal symptom relief by identifying the most effective target for each patient.

In November 2022, Bruker Corporation, a US-based scientific instrument company, acquired Inscopix Inc. for an undisclosed sum. This acquisition aims to advance Inscopix's efforts in enhancing the understanding of neural circuitry related to brain function and behavior, and in developing improved neurotherapeutics in collaboration with biopharma partners. Inscopix Inc., a US-based manufacturer of neuronavigation systems, stands to benefit from this acquisition.

Major companies operating in the neuronavigation systems market are Medtronic PLC, Stryker Corporation (SYK), Zimmer Biomet Holdings Inc., Apollo Hospitals Enterprise Ltd., Carl Zeiss Meditec (AFXA.F), Elekta AB, Renishaw PLC, Brainlab AG, Aesculap Inc., Heal Force Bio-Meditech Holdings Limited, Synaptive Medical, Northern Digital Inc., Magstim TMS, NICO Corporation, Surgical Theater, Ying-Chi TMS, Micromar, NeuroCare Group, MRI Interventions Inc., ClaroNav.

North America was the largest region in the neuronavigation systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuronavigation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuronavigation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Neuronavigation systems are sophisticated medical devices that assist neurosurgeons during brain and spinal surgeries. They offer real-time, accurate, three-dimensional imaging of the patient's anatomy, enabling precise navigation and identification of surgical targets. By significantly enhancing the precision and safety of neurosurgical procedures, neuronavigation systems help surgeons carry out complex operations with increased confidence and success.

There are two primary types of neuronavigation systems optical and electromagnetic. Optical systems use infrared cameras to monitor specialized markers attached to both the surgical instruments and the patient. These systems are employed in various fields, including neurosurgery, craniomaxillofacial surgery, and spinal surgery, and are utilized by diverse end-users such as hospitals, neurology clinics, ambulatory surgical centers, and research facilities.

The neuronavigation systems market research report is one of a series of new reports that provides neuronavigation systems market statistics, including neuronavigation systems industry global market size, regional shares, competitors with a neuronavigation systems market share, detailed neuronavigation systems market segments, market trends, and opportunities, and any further data you may need to thrive in the neuronavigation systems industry. This neuronavigation systems research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuronavigation systems market consists of revenues earned by entities through precise surgical guidance, image fusion and visualization, minimally invasive procedures, and deep brain stimulation (DBS) services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuronavigation systems market consists of sales of tracking devices, computer workstations, navigation instruments, patient registration tools, and visualization tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.